Intended for healthcare professionals

CCBY Open access

Rapid response to:

Research

Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation

BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1226 (Published 03 April 2019) Cite this as: BMJ 2019;365:l1226

Patient perspective

The importance of choice between an insulin pump or multiple daily injections

Author perspective

What is the most effective way to deliver subcutaneous insulin—pumps or injections?

Rapid Response:

Re: Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation

8 April 2019

Dear Editor,
I have just read your article “ Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation” - BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1226 (Published 03 April 2019)

I note that the sample was restricted to young people so I hope the conclusion that the CSII cost is not justified will not be read across too widely. I write to give my experience as an example of other factors which can make a great difference to long term health and the ability of patients to contribute to society and as tax payers.

I started using an insulin pump (CSII) around the same time that I became a barrister, and after having used bolus and basal injections for about 20 years (including an early period without bolus but just 2 injections a day).

Before using CSII I could not cycle or go on long walks without having hypos, treated with sugar, every 10 minutes. It made such activities anti-social and infrequent. Also, when I argue cases in court my blood sugar goes up so much that, prior to having a pump, I had to leave hearings so that I could vomit.

With the CSII I know to increase my basal rate to 150% for all hearings, and some meetings, and I can function as well as if I was not diabetic. Similarly, if I want to cycle or go on a long walk I reduce my basal rate to 20% or sometimes lower.

I am now much more active, very rarely get sick, and am contributing to society and the public purse. I’m sure that others on pumps enjoy similar benefits, so I hope these aspects will be borne in mind by any decision makers in relation to the funding of CSII.

Yours sincerely,

Georgina Hirsch

Competing interests: No competing interests

08 April 2019
Georgina Hirsch
barrister
Temple, London